GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (TSXV:NRX) » Definitions » PB Ratio

NurExone Biologic (TSXV:NRX) PB Ratio : 12.86 (As of Mar. 23, 2025)


View and export this data going back to 2022. Start your Free Trial

What is NurExone Biologic PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-23), NurExone Biologic's share price is C$0.72. NurExone Biologic's Book Value per Share for the quarter that ended in Sep. 2024 was C$0.06. Hence, NurExone Biologic's PB Ratio of today is 12.86.

The historical rank and industry rank for NurExone Biologic's PB Ratio or its related term are showing as below:

TSXV:NRX' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 134
Current: 12.85

During the past 3 years, NurExone Biologic's highest PB Ratio was 134.00. The lowest was 0.00. And the median was 0.00.

TSXV:NRX's PB Ratio is ranked worse than
92.44% of 1283 companies
in the Biotechnology industry
Industry Median: 2.4 vs TSXV:NRX: 12.85

During the past 12 months, NurExone Biologic's average Book Value Per Share Growth Rate was 180.00% per year.

Back to Basics: PB Ratio


NurExone Biologic PB Ratio Historical Data

The historical data trend for NurExone Biologic's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NurExone Biologic PB Ratio Chart

NurExone Biologic Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- 5.91 59.00

NurExone Biologic Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.50 59.00 10.27 12.45 10.18

Competitive Comparison of NurExone Biologic's PB Ratio

For the Biotechnology subindustry, NurExone Biologic's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NurExone Biologic's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NurExone Biologic's PB Ratio distribution charts can be found below:

* The bar in red indicates where NurExone Biologic's PB Ratio falls into.



NurExone Biologic PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

NurExone Biologic's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=0.72/0.056
=12.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


NurExone Biologic  (TSXV:NRX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


NurExone Biologic PB Ratio Related Terms

Thank you for viewing the detailed overview of NurExone Biologic's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NurExone Biologic Business Description

Traded in Other Exchanges
Address
1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9
NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.
Executives
James Angus Wilson (bilkstys-) Richardson 10% Security Holder, Director, Senior Officer

NurExone Biologic Headlines

No Headlines